Solara Active Pharma Sciences' Board reappointed Grant Thornton Bharat LLP as Internal Auditors for FY 2026–27.
The Board also reappointed Mr. M K. Suryanarayanan as Cost Auditors for the same financial year.
Appointments were approved at the Board meeting held on May 15, 2026, under SEBI Listing Regulations.
Disclosure is made as per Regulation 30 and a SEBI Master circular dated January 30, 2026.